Abstract: Chronic pain poses considerable health risks, necessitating the development of effective treatments. Physical modulation of the motor cortex has demonstrated promise for pain relief; however ...
NEW YORK, Nov 12 (Reuters) - The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on data from a handful of patients, two of the ...
The pyrimidine–pyrimidone (6–4) photoproduct (6–4PP) is a UV-induced DNA lesion implicated in skin disorders and cancers. The repair protein XPC/RAD4 detects this lesion and initiates nucleotide ...
Altmetric provides a collated score for online attention across various platforms and media. See more details Parkinson’s disease (PD) is characterized by extensive motor and non-motor dysfunction, ...
Health tech company Doximity bought Pathway Medical to bulk up its healthcare artificial intelligence capabilities as it looks to offer more free AI tools to doctors. The transaction closed July 29 ...
In the published article, there was an error in the legend for Table 1 as published. The legend incorrectly included the abbreviations “MMSE, Mini-Mental State ...
New findings reveal RP1 combined with nivolumab enhances response rates in advanced melanoma, especially with deep tumor injections, showing promising safety and efficacy. An analysis of the phase 2 ...
An artificial intelligence (AI) system for assessing suspicious skin lesions has been conditionally recommended by the National Institute for Health and Care Excellence (NICE) for NHS use in England.
We have moved Health technology evaluation 24 to become HealthTech guidance 746. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback